{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:17:58Z","timestamp":1782937078001,"version":"3.54.5"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejim.2016.05.017","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T03:25:45Z","timestamp":1466220345000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Unique medical issues in adult patients with mucopolysaccharidoses"],"prefix":"10.1016","volume":"34","author":[{"given":"John","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Borgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Braunlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemel A.","family":"Ghotme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne G.","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Molter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klane","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.ejim.2016.05.017_bb0005","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2016.05.017_bb0010","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10545-011-9343-3","article-title":"A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis","volume":"34","author":"Imundo","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10545-012-9559-x","article-title":"Brain magnetic resonance imaging findings in patients with mucopolysaccharidosis VI","volume":"36","author":"Azevedo","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10545-011-9430-5","article-title":"Intellectual and neurological functioning in Morquio syndrome (MPS IVa)","volume":"36","author":"Davison","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/PRM-2010-0104","article-title":"Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: a case series","volume":"3","author":"Scarpa","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.a.36833","article-title":"International guidelines for the management and treatment of Morquio A syndrome","volume":"167A","author":"Hendriksz","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of MPS I: global perspectives from the MPS I Registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"Initial report from the Hunter Outcome Survey","volume":"10","author":"Wraith","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"H\u00e9ron","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","article-title":"The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects","volume":"109","author":"Harmatz","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"Muhlebach","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ejim.2016.05.017_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10545-012-9555-1","article-title":"Respiratory and sleep disorders in mucopolysaccharidosis","volume":"36","author":"Berger","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/PRM-2010-0102","article-title":"Orthopedic management of mucopolysaccharide disease","volume":"3","author":"White","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/14015439.2013.776630","article-title":"Alterations in speech and voice in patients with mucopolysaccharidoses","volume":"39","author":"Nakarat","year":"2014","journal-title":"Logoped Phoniatr Vocol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II \u2013 a historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0080","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/ajmg.a.36584","article-title":"Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux\u2013Lamy syndrome)-10-year follow-up of patients who previously participated in an MPS VI survey study","volume":"164A","author":"Giugliani","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0085","first-page":"59","article-title":"Mortality in patients with Morquio Syndrome A","volume":"15","author":"Lavery","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ejim.2016.05.017_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-010-9113-7","article-title":"Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I","volume":"33","author":"Thomas","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/jmg.19.6.408","article-title":"A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms","volume":"19","author":"Young","year":"1982","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejim.2016.05.017_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.ejim.2016.05.017_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.a.30579","article-title":"Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"134A","author":"Swiedler","year":"2005","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ejim.2016.05.017_bb0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7861\/clinmedicine.12-6-561","article-title":"'Everybody's business': transition and the role of adult physicians","volume":"12","author":"Gleeson","year":"2012","journal-title":"Clin Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1023\/A:1015602601091","article-title":"Growing older: the adult metabolic clinic","volume":"25","author":"Lee","year":"2002","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2016.05.017_bb0125","first-page":"133","article-title":"Mucopolysaccharidosis III (Sanfilippo Syndrome)\u2014disease presentation and experimental therapies","volume":"12","author":"Gilkes","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2016.05.017_bb0130","first-page":"159","article-title":"Mucopolysaccharidosis type VII: a powerful experimental system and therapeutic challenge","volume":"12","author":"Sands","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"issue":"Suppl. 5","key":"10.1016\/j.ejim.2016.05.017_bb0135","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2016.05.017_bb0140","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0145","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2016.05.017_bb0150","first-page":"89","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase","volume":"3","author":"Decker","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10545-012-9481-2","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme\u00ae) therapy","volume":"36","author":"Braunlin","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler\u2013Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0165","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2016.05.017_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1023\/A:1005447232027","article-title":"Bone marrow transplantation for Maroteaux\u2013Lamy syndrome (MPS VI): long-term follow-up","volume":"22","author":"Herskhovitz","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0175","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","article-title":"Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation","volume":"21","author":"Yamada","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejim.2016.05.017_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymgmr.2013.11.002","article-title":"Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA","author":"Chinen","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.ejim.2016.05.017_bb0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10545-011-9410-9","article-title":"Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP)","volume":"36","author":"Hendriksz","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0195","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BPO.0b013e31821f5ee9","article-title":"Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III)","volume":"31","author":"White","year":"2011","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.ejim.2016.05.017_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/PRM-2010-0115","article-title":"Radiologic and neuroradiologic findings in the mucopolysaccharidoses","volume":"3","author":"Lachman","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2016.05.017_bb0205","first-page":"152","article-title":"Therapy for mucopolysaccharidosis VI: (Maroteaux\u2013Lamy syndrome) present status and prospects","volume":"12","author":"Giugliani","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.ejim.2016.05.017_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-9-32","article-title":"Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey","volume":"9","author":"Hendriksz","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11832-014-0601-4","article-title":"Orthopedic management of the extremities in patients with Morquio A syndrome","volume":"8","author":"White","year":"2014","journal-title":"J Child Orthop"},{"key":"10.1016\/j.ejim.2016.05.017_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.a.36833","article-title":"International guidelines for the management and treatment of Morquio A syndrome","volume":"167A","author":"Hendriksz","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0230","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2016.05.017_bb0235","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BPO.0b013e31829abfe0","article-title":"Hip dysplasia in patients with Hurler syndrome (mucopolysaccharidosis type 1H)","volume":"33","author":"Thawrani","year":"2013","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.ejim.2016.05.017_bb0240","first-page":"832439","article-title":"Total hip arthroplasty in mucopolysaccharidosis type IH","volume":"2011","author":"O'heireamhoin","year":"2011","journal-title":"Case Rep Orthop"},{"key":"10.1016\/j.ejim.2016.05.017_bb0245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11926-013-0389-0","article-title":"Mucopolysaccharidoses","volume":"16","author":"Cimaz","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ejim.2016.05.017_bb0250","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","article-title":"Growth charts for patients affected with Morquio A disease","volume":"146A","author":"Monta\u00f1o","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-5876(01)00417-7","article-title":"Disordered breathing during sleep in patients with mucopolysaccharidoses","volume":"58","author":"Leighton","year":"2001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0260","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/ajmg.a.33902","article-title":"Sleep abnormalities in untreated patients with mucopolysaccharidosis type VI","volume":"155A","author":"John","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0265","first-page":"267","article-title":"Management of otolaryngological manifestations in mucopolysaccharidoses: our experience","volume":"33","author":"Mesolella","year":"2013","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.ejim.2016.05.017_bb0270","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ijporl.2014.03.021","article-title":"Mucopolysaccharidosis: otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway","volume":"78","author":"G\u00f6n\u00fcldas","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10545-011-9378-5","article-title":"Hearing loss in patients with mucopolysaccharidosis II: data from HOS \u2013 the Hunter Outcome Survey","volume":"35","author":"Keilmann","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0280","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ymgme.2014.02.003","article-title":"Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses","volume":"111","author":"Lin","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0285","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ijporl.2013.05.003","article-title":"Feasibility of cochlear implantation in Mucopolysaccharidosis","volume":"77","author":"Saeed","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000113511","article-title":"Otologic manifestations of Hunter syndrome and their relationship with speech development","volume":"13","author":"Cho","year":"2008","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0295","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004310050872","article-title":"Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders \u2013 clinical and echocardiographic findings in 64 patients","volume":"157","author":"Dangel","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejim.2016.05.017_bb0300","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S1047951109003576","article-title":"The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses","volume":"19","author":"Fesslov\u00e1","year":"2009","journal-title":"Cardiol Young"},{"key":"10.1016\/j.ejim.2016.05.017_bb0305","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S104795110999062X","article-title":"Echocardiographic study of paediatric patients with mucopolysaccharidosis","volume":"20","author":"Leal","year":"2010","journal-title":"Cardiol Young"},{"key":"10.1016\/j.ejim.2016.05.017_bb0310","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1651-2227.2002.tb03330.x","article-title":"Cardiovascular changes in children with mucopolysaccharide disorders","volume":"91","author":"Mohan","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ejim.2016.05.017_bb0315","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10545-012-9459-0","article-title":"Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA","volume":"36","author":"Hendriksz","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0320","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Monta\u00f1o","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejim.2016.05.017_bb0325","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0330","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10545-013-9649-4","article-title":"Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy","volume":"37","author":"Kampmann","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0335","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/ajmg.a.35905","article-title":"Mucopolysaccharidosis type VI: a predominantly cardiac phenotype associated with homozygosity for p.R152W mutation in the ARSB gene","volume":"161A","author":"Jurecka","year":"2013","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0340","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF01991908","article-title":"Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses","volume":"154","author":"Wippermann","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejim.2016.05.017_bb0345","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10545-012-9474-1","article-title":"Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series","volume":"35","author":"Th\u00fcmler","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0350","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2169\/internalmedicine.49.4210","article-title":"Atrioventricular block and diastolic dysfunction in a patient with Sanfilippo C","volume":"49","author":"Misumi","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.carpath.2006.11.009","article-title":"Left ventricular aneurysm in a patient with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): clinical and pathological correlation","volume":"16","author":"Oudit","year":"2007","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0360","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9149(81)90550-6","article-title":"Coronary artery disease in the Hurler syndrome. Qualitative and quantitative analysis of the extent of coronary narrowing at necropsy in six children","volume":"47","author":"Brosius","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0365","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajmg.a.34371","article-title":"Retrospective analysis of the clinical manifestations and survival of Korean patients with mucopolysaccharidosis type II: emphasis on the cardiovascular complication and mortality cases","volume":"158A","author":"Sohn","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0370","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2011.01.054","article-title":"Prevalence and characterization of cardiac involvement in Hunter syndrome","volume":"159","author":"Kampmann","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejim.2016.05.017_bb0375","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0887-8994(96)00083-5","article-title":"Sanfilippo syndrome type C: a clinicopathological autopsy study of a long-term survivor","volume":"14","author":"Kurihara","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0380","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","article-title":"Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder","volume":"109","author":"Yasuda","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0385","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ymgme.2011.09.004","article-title":"Carotid intima-media thickness is increased in patients with mucopolysaccharidoses","volume":"104","author":"Wang","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0390","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2013.11.001","article-title":"Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness","volume":"111","author":"Wang","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0395","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10545-011-9438-x","article-title":"Endothelial function in children and adolescents with mucopolysaccharidosis","volume":"36","author":"Kelly","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0400","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1097\/01.ASN.0000037677.16961.DF","article-title":"Increased arterial stiffness in young adults with end-stage renal disease since childhood","volume":"13","author":"Groothoff","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-012-9500-3","article-title":"Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience","volume":"36","author":"Wiseman","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0410","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0415","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.athoracsur.2007.03.042","article-title":"Surgical treatment for mitral stenosis in Scheie's syndrome: mucopolysaccharidosis type I-S","volume":"84","author":"Kitabayashi","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejim.2016.05.017_bb0420","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1016\/j.ijcard.2013.12.233","article-title":"Management of aortic stenosis in mucopolysaccharidosis type I","volume":"172","author":"Felice","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0425","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ajmg.a.20068","article-title":"Late-onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndrome","volume":"118A","author":"Van Hove","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2016.05.017_bb0430","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.carpath.2011.10.004","article-title":"The first cardiac transplant experience in a patient with mucopolysaccharidosis","volume":"21","author":"Grinberg","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0435","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1253\/jcj.62.700","article-title":"Surgical treatment for Scheie's syndrome (mucopolysaccharidosis type I-S). Report of two cases","volume":"62","author":"Minakata","year":"1998","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ejim.2016.05.017_bb0440","first-page":"13","article-title":"Postmortem findings in the Hurler\u2013Scheie syndrome (mucopolysaccharidosis I-H\/S)","volume":"18","author":"Wassman","year":"1982","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.ejim.2016.05.017_bb0445","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s10545-005-0211-x","article-title":"Mucopolysaccharidosis I under enzyme replacement therapy with laronidase \u2013 a mortality case with autopsy report","volume":"28","author":"Lin","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0450","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-013-9586-2","article-title":"Spinal involvement in mucopolysaccharidosis IVA (Morquio\u2013Brailsford or Morquio A syndrome): presentation, diagnosis and management","volume":"36","author":"Solanki","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0455","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgme.2012.07.018","article-title":"A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI","volume":"107","author":"Solanki","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2014.10.010","article-title":"Diagnostic evaluation, monitoring, and perioperative management of spinal cord compression in patients with Morquio syndrome","volume":"114","author":"Charrow","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2016.05.017_bb0465","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clineuro.2004.05.003","article-title":"Multilevel myelopathy in Maroteaux\u2013Lamy syndrome and review of the literature","volume":"107","author":"Mut","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ejim.2016.05.017_bb0470","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10545-013-9591-5","article-title":"Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery","volume":"36","author":"Lampe","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2005.11.007","article-title":"Mucopolysaccharidoses and the eye","volume":"51","author":"Ashworth","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0480","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1442-9071.2010.02364.x","article-title":"Ocular manifestations in the mucopolysaccharidoses \u2013 a review","volume":"38","author":"Ashworth","year":"2010","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0485","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1755-3768.2011.02280.x","article-title":"Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis","volume":"90","author":"Fahnehjelm","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"Suppl. 5","key":"10.1016\/j.ejim.2016.05.017_bb0490","doi-asserted-by":"crossref","first-page":"v34","DOI":"10.1093\/rheumatology\/ker392","article-title":"Ocular manifestations as key features for diagnosing mucopolysaccharidoses","volume":"50","author":"Summers","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2016.05.017_bb0495","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1460-9592.2012.03825.x","article-title":"A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses","volume":"22","author":"Frawley","year":"2012","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.ejim.2016.05.017_bb0500","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10545-012-9563-1","article-title":"Anaesthesia and airway management in mucopolysaccharidosis","volume":"36","author":"Walker","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2016.05.017_bb0505","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.22774","article-title":"Characterization of pulmonary function impairments in patients with mucopolysaccharidoses \u2013 changes with age and treatment","volume":"49","author":"Lin","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ejim.2016.05.017_bb0510","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1365-2044.1994.tb04360.x","article-title":"Anaesthesia and mucopolysaccharidoses. A review of airway problems in children","volume":"49","author":"Walker","year":"1994","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejim.2016.05.017_bb0515","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/PRM-2010-0103","article-title":"Clinical assessment and treatment of carpal tunnel syndrome in the mucopolysaccharidoses","volume":"3","author":"White","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"key":"10.1016\/j.ejim.2016.05.017_bb0520","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0363-5023(98)80120-2","article-title":"Surgical treatment of carpal tunnel syndrome and trigger digits in children with mucopolysaccharide storage disorders","volume":"23","author":"Van Heest","year":"1998","journal-title":"J Hand Surg [Am]"},{"key":"10.1016\/j.ejim.2016.05.017_bb0525","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-263x.1999.00127.x","article-title":"Dental findings in three siblings with Morquio's syndrome","volume":"9","author":"R\u00f8lling","year":"1999","journal-title":"Int J Paediatr Dent"},{"key":"10.1016\/j.ejim.2016.05.017_bb0530","first-page":"3421","volume":"8","author":"Neufeld","year":"2001","journal-title":"Mucopolysaccharidoses"},{"key":"10.1016\/j.ejim.2016.05.017_bb0535","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/CIRCULATIONAHA.113.005817","article-title":"Specialized adult congenital heart disease care: the impact of policy on mortality","volume":"129","author":"Mylotte","year":"2014","journal-title":"Circulation"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516301339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516301339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T10:05:27Z","timestamp":1600769127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516301339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":107,"alternative-id":["S0953620516301339"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.05.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique medical issues in adult patients with mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}